Related Experiment Video
Updated: Jun 15, 2025

Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
Unraveling metastatic timing: insights and challenges from genomic evolution
Qiu-Luo Liu1, Zong-Guang Zhou2, Ziqiang Wang3
1Colorectal Cancer Center, Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041, PR China; Institute of Digestive Surgery, Institute of General Surgery, West China Hospital, Sichuan University, Chengdu 610041, PR China.
None:
Metastasis, a significant hurdle in cancer treatment, is driven by genetic alterations that shape tumor evolution and dissemination. Traditionally viewed as a late-stage event, recent evidence suggests that metastasis may initiate earlier in tumor progression than previously assumed. Genomic studies have been instrumental in exploring this complex process, yet inconsistencies persist, with findings supporting both early and late metastatic events. These discrepancies are likely due to methodological variations in how metastasis timing is inferred. Additionally, biases in sampling and the heterogeneity of metastatic seeding further obscure precise assessments of metastatic divergence. Addressing these challenges is essential to refining evolutionary models of metastasis, which will be crucial for advancing cancer research and improving therapeutic strategies. In this review, we examine the challenges in accurately timing metastatic events and discuss how insights into early versus late dissemination can inform personalized therapeutic strategies. Such perspectives can lead to more personalized and effective cancer management.
More Related Videos
Related Concept Videos
Gene Evolution - Fast or Slow?
In contrast, regions which code...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Genome Size and the Evolution of New Genes
Cancers Originate from Somatic Mutations in a Single Cell
Evolutionary Relationships through Genome Comparisons

